SCHEMBL25285702

SCHEMBL25285702

CCC(C)(C(=O)NOc1cc(C)nn1-c1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 1/20 0.43
LMNA P02545 1/20 0.43
STAT1 P42224 1/20 0.43
ALDH1A1 P00352 3/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
GAA P10253 2/20 0.42
ATM Q13315 1/20 0.42
P2RY1 P47900 2/20 0.41
TSHR P16473 1/20 0.40
KCNJ6 P48051 1/20 0.40
KCNJ5 P48544 1/20 0.40
KCNJ3 P48549 1/20 0.40
HPGD P15428 1/20 0.40
CYP1A2 P05177 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
MAPT P10636 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21753619 0.85 NTRK1 (0.50) NTRK1LMNASTAT1ALDH1A1HTT
SCHEMBL28364643 0.83 NTRK1 (0.42) NTRK1LMNASTAT1ALDH1A1HTT
SCHEMBL21753616 0.80 ALDH1A1 (0.50) NTRK1LMNASTAT1ALDH1A1HTT
SCHEMBL21753627 0.78 ALDH1A1 (0.48) NTRK1LMNASTAT1ALDH1A1HTT
SCHEMBL21753629 0.75 P2RY1 (0.51) NTRK1LMNASTAT1ALDH1A1KMT2A
SCHEMBL20320310 0.74 KMT2A (0.54) NTRK1LMNASTAT1ALDH1A1KMT2A
SCHEMBL21753652 0.73 KMT2A (0.51) NTRK1LMNASTAT1ALDH1A1KMT2A
SCHEMBL21753656 0.73 ALDH1A1 (0.46) NTRK1LMNASTAT1ALDH1A1HTT
SCHEMBL21753642 0.72 NTRK1 (0.47) NTRK1LMNASTAT1ALDH1A1KMT2A
SCHEMBL21753653 0.72 P2RY1 (0.48) NTRK1ALDH1A1KMT2AL3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11692004-B2 Substituted pyrazole compound, preparation method therefor, pharmaceutical composition and medical use thereof JIANGSU VANGUARD PHARMACEUTICAL CO., LTD. (CN) 2023-07-04 US disclosed
US-20220372058-A1 Substituted Pyrazole Compound, Preparation Method Therefor, Pharmaceutical Composition and Medical Use Thereof JIANGSU VANGUARD PHARMACEUTICAL CO., LTD (CN) 2022-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220372058-A1 Substituted Pyrazole Compound, Preparation Method Therefor, Pharmaceutical Composition and Medical Use Thereof FARS2, GOT2, HADHB NTRK1 2744/4885LMNA 360/4885STAT1 4117/4885
US-11692004-B2 Substituted pyrazole compound, preparation method therefor, pharmaceutical composition and medical use thereof FARS2, GOT2, HADHB NTRK1 2744/4885LMNA 360/4885STAT1 4117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.